Hopex Pharmaceuticals Private Limited

Hopex Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U51909DL2020PTC373693 Incorporated 25 November 2020 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹1.21 Cr
▲ 55% YoY
Net profit · FY 2025
₹2.56 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹4.48 Lakh
EBITDA margin 3.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Hopex Pharmaceuticals Private Limited

Data last updated:

Hopex Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 November 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2020PTC373693. Its GSTIN is 07AAFCH5561B1ZU (Delhi).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rahul Dev and Krishna Kumar Verma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. G – 8 G/F Csc 2 Vardhman Grand Market Sec – 3 Dwarka, Delhi, India – 110078.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.21 Cr, a growth of 55% compared to the previous year. For the same year it recorded a net profit of ₹2.56 Lakh (net margin 2.1%) and EBITDA of ₹4.48 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 97% over three years.

Hopex Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0008619). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909DL2020PTC373693
Registration Number 373693
Incorporation Date 25 November 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0008619

Recognitions & Rankings of Hopex Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-DL-11-0008619

Contact details

Hopex Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shop No. G – 8 G/F Csc 2 Vardhman Grand Market Sec – 3 Dwarka, Delhi, India – 110078
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Hopex Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Hopex Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Hopex Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHuman health and social work activities86Human health activities

To see the full business activity and turnover split of Hopex Pharmaceuticals Private Limited, buy the company report.

Financials of Hopex Pharmaceuticals Private Limited

FY 2025 filings available

Hopex Pharmaceuticals Private Limited reported revenue of ₹1.21 Cr (up 55% YoY) for FY 2025.

Revenue · FY 2025
₹1.21 Cr ▲ 55%
Net profit · FY 2025
₹2.56 Lakh margin 2.1%
EBITDA · FY 2025
₹4.48 Lakh margin 3.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 55%
3 years · compounded
▲ 97%
EBITDA CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 36%

Revenue has grown at a compounded annual rate (CAGR) of 97% over three years, including 55% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.48 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.56 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.7%
Net Profit Margin2.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hopex Pharmaceuticals Private Limited, buy the company report.

Board of directors of Hopex Pharmaceuticals Private Limited

Hopex Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rahul DevDirector16 Apr 20215 Years 6 MonthsCurrent
Krishna Kumar VermaDirector25 Nov 20205 Years 11 MonthsCurrent
Rajeev KumarDirector17 Jun 20251 Years 4 MonthsCurrent

Auditor

Hopex Pharmaceuticals Private Limited is audited by NAVEEN SINGH & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
NAVEEN SINGH & COFY 2021015782N

Shareholding

The shareholding of Hopex Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Hopex Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hopex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Hopex Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 13, 2026.

Active EPFO establishments
1

GST

Hopex Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAFCH5561B1ZUDelhiActive24 Dec 2020

To see the full GST registrations and return filing status of Hopex Pharmaceuticals Private Limited, buy the company report.

Recent activity

Hopex Pharmaceuticals Private Limited has 5 board changes on record since 2020: 3 appointments and 2 cessations. The latest: Rajeev Kumar was appointed as Director on 17 Jun 2025.

AGM
Hopex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Rajeev Kumar was appointed as Director.
Filing
Hopex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Lokesh Talwar ceased to be Director.
Ceased
Yad Ram Singh ceased to be Director.
Appointed
Rahul Dev was appointed as Director.
Appointed
Krishna Kumar Verma was appointed as Director.
Incorporation
25 Nov 2020
Hopex Pharmaceuticals Private Limited was registered on 25 Nov 2020 with Roc Delhi & aged 5 years 11 months as per MCA records.

Frequently asked questions

Hopex Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 November 2020 (6+ years old) and is registered under CIN U51909DL2020PTC373693.

Hopex Pharmaceuticals has 3 current directors:

The latest financial statements of Hopex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Hopex Pharmaceuticals is 07AAFCH5561B1ZU, registered in Delhi.

The CIN (Corporate Identification Number) of Hopex Pharmaceuticals is U51909DL2020PTC373693. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hopex Pharmaceuticals was incorporated on 25 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

Rajeev Kumar was appointed as Director on 17 Jun 2025. Lokesh Talwar ceased to be Director on 23 Nov 2024. Yad Ram Singh ceased to be Director on 16 Nov 2021. Hopex Pharmaceuticals has 5 board changes on record in total.

Yes, Hopex Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0008619).

The registered office of Hopex Pharmaceuticals is at Shop No. G – 8 GF Csc 2 Vardhman Grand Market Sec – 3 Dwarka, Delhi, India – 110078.

Hopex Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.